Suppr超能文献

用于 COPD 运动能力的台阶试验的测量特性:系统评价。

Measurement properties of step tests for exercise capacity in COPD: A systematic review.

机构信息

Department of Physiotherapy and Center for Rehabilitation Research, School of Health, Polytechnic Institute of Porto, Porto, Portugal.

Healthcare Department, Nippon Gases Portugal, Lisbon, Portugal.

出版信息

Clin Rehabil. 2021 Apr;35(4):578-588. doi: 10.1177/0269215520968054. Epub 2020 Nov 6.

Abstract

OBJECTIVE

To determine the level of evidence of the measurement properties (validity, reliability, and responsiveness) and interpretability of the step tests available for assessing the exercise capacity in patients with chronic obstructive pulmonary disease.

DATA SOURCES

The data sources Web of Science, MEDLINE, PubMed, PEDro, CENTRAL of Cochrane Library, and Scopus were searched up to June 26, 2020.

REVIEW METHODS

Studies of any design that reported results for any measurement property of the step tests for assessing the exercise capacity in COPD patients were selected. One reviewer extracted the data, and two reviewers independently rated the level of evidence by using the Consensus-Based Standards for the Selection of Health Measurements Instruments recommendations.

RESULTS

Thirty-one studies were included in the data synthesis. Chester Step Test, Modified Incremental Step Test, two-, three-, four-, and six-Minute Step Test, Paced Step Test, and six-Minute Stepper Test were identified. A step test protocol was also found. The level of evidence of their results for the measurement properties was mostly determined as "low" to "very low." The best level of evidence found was for the six-minute stepper test: "high" on construct validity ( = 0.56-0.71); and "moderate" on criterion validity ( = 0.36-0.69), and responsiveness ( = 0.26-0.34).

CONCLUSION

The general level of evidence of the measurement properties of the step tests is "low" to "very low" for assessing exercise capacity in patients with chronic obstructive pulmonary disease, which can limit their application in clinical practice. The six-minute Stepper Test is currently the most appropriate step test available.

摘要

目的

确定评估慢性阻塞性肺疾病患者运动能力的台阶试验的测量性能(有效性、可靠性和反应度)和可解读性的证据水平。

资料来源

截至 2020 年 6 月 26 日,我们在 Web of Science、MEDLINE、PubMed、PEDro、Cochrane 图书馆的 CENTRAL 和 Scopus 数据库中搜索了资料。

审查方法

我们选择了报告用于评估 COPD 患者运动能力的台阶试验的任何测量性能的研究。一位审查员提取了数据,两位审查员独立使用共识标准选择健康测量仪器建议来评估证据水平。

结果

31 项研究被纳入数据综合分析。我们发现了 Chester 台阶试验、改良递增台阶试验、2 分钟、3 分钟、4 分钟和 6 分钟台阶试验、 paces 台阶试验和 6 分钟踏步器试验。还发现了一个台阶试验方案。其测量性能结果的证据水平大多被确定为“低”到“极低”。发现的最佳证据水平是 6 分钟踏步器试验:构建有效性为“高”( = 0.56-0.71);标准有效性为“中”( = 0.36-0.69),反应度为“中”( = 0.26-0.34)。

结论

评估慢性阻塞性肺疾病患者运动能力的台阶试验的测量性能的总体证据水平为“低”到“极低”,这可能限制了它们在临床实践中的应用。6 分钟踏步器试验目前是最适合的台阶试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d245/8027930/3b34f000778f/10.1177_0269215520968054-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验